Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RATHER: Early vs Late Anticoagulation Resumption
NCT02091479Phase 3Terminated
- Sponsor
- CHU Saint-Etienne
- Start
- Jan 2013
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin, low molecular weight heparin calcium in thrombosis, thromboembolism, sponsored by CHU Saint-Etienne. Started Jan 2013; status: terminated.
02
Drugs
heparinlow molecular weight heparin calcium
03
Conditions
thrombosisthromboembolism
Beyond the preview
Go deeper on NCT02091479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091479.